|
Bartek, J., Bartkova, J., and Lukas, J. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8: 805-814.
Bates, S., Phillips, A. C. Clark, P.A., Stott, F. Peters, G. Ludwig, R. L., Vousden, K. 1998. p14ARF links the tumor suppressor Rb and p53. Nature 395: 124-125.
Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA. 1999. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after g-irradiation. Proc Natl Acad Sci USA:96:1002–7.
Catherino W., Phyllis C., Matthew H. 2004. Reduced Dermatopontin Expression Is a Molecular Link Between Uterine Leiomyomas and Keloids. Genes, Chromosomes & Cancer 40:204–217.
Classon, M. and Dyson, N. 2001. p107 and 130: versatile proteins with interesting pockets. Exp. Cell Res. 264: 135-147.
Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245-62.
el-Deiry WS, Harper JW, O’Connor PM.1994. WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res:54: 1169–74.
DeCaprio, J. A. et al. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell: 54: 275-283.
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., and Kemp, C. J. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396:177–180.
Forbes, E., Cronshaw, A., MacBeath, J. and Hulmes, D. 1994. FEBS Lett. 351, 433±436
Guan, K-L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O’Keefe, C. L., Matera, A. G., and Xiong, Y. 1994. Growth suppression by p18, a p16INK4/MTS1- and p15INK4B/MTS2- related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8: 2939–2952.
Helin, K., Harlow, E. and Fatty, A. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6508.
Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K., Lu, X. 1997. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11: 1840-1852.
Knudson, A. G. Jr. 1978. Retinoblastoma: a prototypic hereditary neoplasm. Semin. Oncol. 5:57-60.
Kokenyesi R, Woessner JF. 1991. Effects of hormonal perturbations on the small dermatan sulfate proteoglycan and mechanical properties of the uterine cervix of late pregnant rats. Connect Tissue Res 26:199 –205.
Lewandowska K, Choi HU, Rosenberg LC, Sasse J, Neame PJ, Culp LA. 1991. Extracellular matrix adhesion-promoting activities of a dermatan sulfate roteoglycan- associated protein (22K) from bovine fetal skin. J Cell Sci 99:657–68.
Luca A, Manoranjan Santra, Alfonso Baldi, Antonio Giordano, and Renato V. Iozzo, 1996. Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases. J.. Biol. Chem. 271, 18961–18965
MacBeath JR, Shackleton DR, Hulmes DJ. 1993. Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro. J Biol Chem 268:19826 –19832.
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., and Sherr, C. J. 1992. Identification and properties of an atypical catalytic subunit (p34PSKJ3/CDK4) for mammalian D-type G1 cyclins. Cell, 71: 323–334.
Mulligan, G. and Jacks, J. 1998.The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14: 223–229.
Nash MA, Deavers MT, Freedman RS. 2002. The expression of decorin in human ovarian tumors. Clin Cancer Res 8:1754–60.
Okamoto, O., Suzuki, Y., Kimura, S. and Shinkai, H. 1996. Extracellular matrix 22-kDa protein interacts with decorin core protein and is expressed in cutaneous fibrosis. J. Biochem. (Tokyo) 119, 106±114
Okamoto O, Fujiwara S, Abe M, Sato Y. 1999. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. Biochem J 337:537–541.
Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R., Vousden, K. H. 1999. E2F-1 potentiates cell death by blocking anti-apoptotic signaling pathways. Mol. Cell. 4: 771-781.
Richard W. Padgett, Seo-Hee Cho and Carlos Evangelista. 1998. Smads Are the Central Component in Transforming Growth Factor-b Signaling. Pharmacol. Ther. Vol. 78, No. 1, pp. 47–52.
Ruas, M., and Peters, G. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta Rev. Cancer, 1378: F115–F177.
Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. 1995. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92:7016–20.
Sherr, C. J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672-1677.
Superti-Furga A, Rocchi M, Schafer BW, Gitzelmann R. 1993. Complementary DNA sequence and chromosomal mapping of a human proteoglycan-binding cell-adhesion protein (dermatopontin).Genomics 17:463– 467.
Varga J, Rosenbloom J, Jimenez SA. 1987. Transforming growth factor β (TGF β) causes a persistent increase in steadystate amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597–604
Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW 1995. Serial Analysis Of Gene Expression. Science 270, 484-487.
Vlach, J., Hennecke, S., and Amati, B. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J., 16: 5334–5344.
Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
Xiong, Y., Connolly, T., Futcher, B., and Beach, D. 1991. Human D-type cyclin. Cell, 65:691–699.
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW. 1997. Gene expression profiles in normal and cancer cells. Science 276(5316):1268-72.
|